Lebwohl David
- SEC CIK
- 0001810882
In the past year, 1 open-market sale filing worth $109.6K and no purchases.
Current role at each company
- NTLA Intellia Therapeutics, Inc.EVP, Chief Medical Officeras of Mar 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $109.6K
- 1 filing
- Net
- −$109.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lebwohl David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 7, 2026 (view filing) | Jan 5 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −11.9K | $9.21 | −$109.6K | −8.9%121.2K after | |
| Jan 7, 2025 (view filing) | Jan 3 | 4 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −9.56K | $12.18 | −$116.4K | −9.8%87.7K after | |
| Jan 5, 2024 (view filing) | Jan 3 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −5.84K | $29.46 | −$172.1K | −9.7%54.4K after | |
| Jan 6, 2023 (view filing) | Jan 4 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.57K | $37.21 | −$95.8K | −9.1%25.7K after | |
| Mar 3, 2022 (view filing) | Jan 1 | 61 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −1.05K | $112.24 | −$118.0K | −8.8%10.9K after | Amended |
| Nov 9, 2021 (view filing) | Nov 5 | 4 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.40K | $132.72 | −$318.5K | −21.6%8.71K after | 4 lots |
| Oct 15, 2021 (view filing) | Oct 14 | 1 day | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.40K | $128.44 | −$308.2K | −21.6%8.71K after | 5 lots |
| Sep 23, 2021 (view filing) | Sep 21 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.40K | $149.81 | −$359.5K | −75.2%791 after | |
| Sep 1, 2021 (view filing) | Aug 30 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.40K | $158.04 | −$379.3K | −75.2%791 after | 5 lots |
| Aug 11, 2021 (view filing) | Aug 9 | 2 days | Lebwohl DavidEVP, Chief Medical Officer | SSale | −2.40K | $164.05 | −$393.7K | −75.2%791 after |